These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 794060)
1. Quantitative determination of cholestanol in plasma with mass fragmentography. Biochemical diagnosis of cerebrotendinous xanthomatosis. Seyama Y; Ichikawa K; Yamakawa T J Biochem; 1976 Aug; 80(2):223-8. PubMed ID: 794060 [TBL] [Abstract][Full Text] [Related]
2. Biochemical diagnosis of cerebrotendinous xanthomatosis using reversed phase thin layer chromatography. Kasama T; Seyama Y J Biochem; 1986 Mar; 99(3):771-5. PubMed ID: 3086296 [TBL] [Abstract][Full Text] [Related]
3. Capillary gas chromatographic determination of cholestanol/cholesterol ratio in biological fluids. Its potential usefulness for the follow-up of some liver diseases and its lack of specificity in diagnosing CTX (cerebrotendinous xanthomatosis). Koopman BJ; van der Molen JC; Wolthers BG; de Jager AE; Waterreus RJ; Gips CH Clin Chim Acta; 1984 Mar; 137(3):305-15. PubMed ID: 6421514 [TBL] [Abstract][Full Text] [Related]
4. Simplified determination of cholestanol in serum by gas-liquid chromatography: biochemical diagnosis of cerebrotendinous xanthomatosis. Serizawa S; Seyama Y; Otsuka H; Kasama T; Yamakawa T J Biochem; 1981 Jul; 90(1):17-21. PubMed ID: 7287675 [TBL] [Abstract][Full Text] [Related]
5. Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid. Salen G; Berginer V; Shore V; Horak I; Horak E; Tint GS; Shefer S N Engl J Med; 1987 May; 316(20):1233-8. PubMed ID: 3106810 [TBL] [Abstract][Full Text] [Related]
6. Stable isotope dilution assay for 5 beta-cholestane-3 alpha,7 alpha,12 alpha,25-tetrol and 5 beta-cholestane-3 alpha,7 alpha,12 alpha,23,25-pentol in human serum using [26,27-D6] labeled internal standards; a highly accurate approach to the serological diagnosis of cerebrotendinous xanthomatosis. Kosaka D; Hiraoka T; Kohoda T; Kajiyama G; Yamauchi T; Kihira K; Kuramoto T; Hoshita T Clin Chim Acta; 1991 May; 199(1):83-9. PubMed ID: 1934504 [No Abstract] [Full Text] [Related]
7. Isolation of 5 alpha-cholestane-3 beta, 7 alpha-diol from bile of patients with cerebrotendinous xanthomatosis. Inefficiency of this steroid as a precursor to cholestanol. Björkhem I; Buchmann MS; Skrede S Biochim Biophys Acta; 1983 Sep; 753(2):220-6. PubMed ID: 6412759 [TBL] [Abstract][Full Text] [Related]
8. Comparative effects of lovastatin and chenodeoxycholic acid on plasma cholestanol levels and abnormal bile acid metabolism in cerebrotendinous xanthomatosis. Salen G; Batta AK; Tint GS; Shefer S Metabolism; 1994 Aug; 43(8):1018-22. PubMed ID: 8052141 [TBL] [Abstract][Full Text] [Related]
9. The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosis. Salen G; Grundy SM J Clin Invest; 1973 Nov; 52(11):2822-35. PubMed ID: 4355999 [TBL] [Abstract][Full Text] [Related]
10. Isotopomer spectral analysis of intermediates of cholesterol synthesis in patients with cerebrotendinous xanthomatosis. Clarenbach JJ; Lindenthal B; Dotti MT; Federico A; Kelleher JK; von Bergmann K Metabolism; 2005 Mar; 54(3):335-44. PubMed ID: 15736111 [TBL] [Abstract][Full Text] [Related]
11. [Laboratory diagnosis of a rare congenital neurodegenerative disease: cerebrotendinous xanthomatosis]. Varga VE; Katkó M; Harangi J; Balogh I; Kapás I; Madar L; Seres I; Molnár MJ; Paragh G; Kovács GG; Harangi M Orv Hetil; 2014 May; 155(21):811-6. PubMed ID: 24836315 [TBL] [Abstract][Full Text] [Related]
12. Age-related changes of cholestanol and lathosterol plasma concentrations: an explorative study. Gelzo M; Di Taranto MD; Sica C; Boscia A; Papagni F; Fortunato G; Corso G; Dello Russo A Lipids Health Dis; 2019 Dec; 18(1):235. PubMed ID: 31888647 [TBL] [Abstract][Full Text] [Related]
13. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis. Salen G; Shefer S; Tint GS Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073 [TBL] [Abstract][Full Text] [Related]
14. A Multiplex Phytosterol Assay Utilizing Gas Chromatography-Mass Spectrometry for Diagnosis of Inherited Lipid Storage Disorders. Lee JH; Lee K; Jun SH; Song SH; Shin CH; Song J Ann Lab Med; 2019 Jul; 39(4):411-413. PubMed ID: 30809990 [No Abstract] [Full Text] [Related]
15. Magnetic resonance imaging of the brain and spinal cord in cerebrotendinous xanthomatosis. Bencze KS; Vande Polder DR; Prockop LD J Neurol Neurosurg Psychiatry; 1990 Feb; 53(2):166-7. PubMed ID: 2107278 [TBL] [Abstract][Full Text] [Related]
16. A novel pathway for biosynthesis of cholestanol with 7 alpha-hydroxylated C27-steroids as intermediates, and its importance for the accumulation of cholestanol in cerebrotendinous xanthomatosis. Skrede S; Björkhem I; Buchmann MS; Hopen G; Fausa O J Clin Invest; 1985 Feb; 75(2):448-55. PubMed ID: 3919058 [TBL] [Abstract][Full Text] [Related]
17. Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in The Netherlands. Koopman BJ; Wolthers BG; van der Molen JC; van der Slik W; Waterreus RJ; van Spreeken A J Inherit Metab Dis; 1988; 11(1):56-75. PubMed ID: 3128689 [TBL] [Abstract][Full Text] [Related]
18. Could steroids mask the diagnosis of cerebrotendinous xanthomatosis? Siman-Tov T; Meiner V; Gadoth N J Neurol Sci; 2006 Apr; 243(1-2):83-6. PubMed ID: 16445943 [TBL] [Abstract][Full Text] [Related]
19. Plasma and biliary cholestanol related to steroid metabolism in familial hypercholesterolemia patients with and without ileal exclusion. Koivisto PV; Miettinen TA Clin Chim Acta; 1988 May; 174(2):197-205. PubMed ID: 3133140 [TBL] [Abstract][Full Text] [Related]
20. Increased serum cholestanol in patients with cerebrotendinous xanthomatosis (CTX): chromatographic study. Michalec C Acta Univ Carol Med (Praha); 1988; 34(1-2):111-6. PubMed ID: 3152022 [No Abstract] [Full Text] [Related] [Next] [New Search]